Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
ABUS compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name
ABUS
Arbutus Biopharma Corp
Change
Mkt cap
Revenue
Revenue
LLY
ELI Lilly & Co
Change
Mkt cap
Revenue
Revenue
vs
Compare
ABUS
Arbutus Biopharma Corp
vs
LLY
ELI Lilly & Co
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Co-movers
Desk
News
Calendar
Saved
Search
ABUS
Arbutus Biopharma Corp
Change
3.89
· pre 3.86
· delayed
Mkt cap
$767.6M
Revenue
$1M
Q2 FY26
Revenue
$14M
FY25
LLY
ELI Lilly & Co
Change
1,407.25
· pre 1,437.55
· delayed
Pre-market
Nov 4 '26
delayed
Mkt cap
$1.3T
Revenue
$24.4B
Q3 FY26
Revenue
$65.2B
FY25
vs
Compare
Pre-market
Nov 4 '26
delayed
ABUS
Arbutus Biopharma Corp
vs
LLY
ELI Lilly & Co
3.89
pre 3.86
delayed
Price
1,407.25
pre 1,437.55
delayed
$767.6M
Mkt cap
$1.3T
Q2 FY26
$1M
Revenue
$24.4B
Q3 FY26
FY25
$14M
Revenue
$65.2B
FY25
Change
Change
ABUS
3.89
vs
LLY
1,407.25
Pre-market
Nov 4 '26
delayed
Co-movers
daily closes · 500d
Method
›
Moved together
ABUS
with
LLY
×0.22
co-movement · LLY on ABUS · 500d
r 0.26
scale to r 0.75
No shared co-movers.
ABUS, solid
LLY, hatched
× = co-movement · β
r = correlation
Bar = r to r 0.75
Source: daily closes